

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
"The safety of mifepristone has never actually been in question," said one advocate. "As this case moves towards the US Supreme Court, we will fight until every person has access to the care they need."
A pharmaceutical company which manufactures mifepristone filed an appeal to the US Supreme Court on Saturday asking for emergency relief from the "sweeping and dangerous" lower-court ruling Friday that would prohibit the mailing of the widely used abortion medication nationwide.
Danco Laboratories, which makes the popular drug and is part of ongoing litigation stemming from a legal challenge by the Republican-controlled state of Louisiana, said Friday's ruling by the Fifth Circuit of Appeals—a decision roundly condemned by reproductive rights advocates as an attack on women's health and the right to choose across the country—will cause "tremendous uncertainty" on the "legal status of mifepristone throughout the country” if it goes into effect.
The company further argued that the ruling as it stands leaves medical providers, patients, and pharmacies “all to guess at what is allowed and what is not," whether or not abortion is legal in the state where a patient is trying to obtain it.
The company asked the nation's highest court for an immediate administrative stay to the 5th Circuit's ruling while the challenge to the drug's availability makes its way through lower courts. It also urged the Court to take up the case itself prior to the upcoming summer recess.
According to Politico:
Even a temporary disruption of access to mifepristone will have massive implications. The medication is used in nearly two-thirds of all pregnancy terminations, and a quarter of patients depend on telehealth to obtain them. The ruling also cuts off telemedicine prescription of the drug for non-abortion purposes, such as easing miscarriages.
In the wake of Friday’s ruling, medical and progressive advocacy groups stressed that doctors can still use telehealth to prescribe the other abortion pill — misoprostol. The drug can be used on its own to end pregnancies and carries fewer restrictions because it is used for an array of other purposes, including treating ulcers and stopping hemorrhages.
Skye Perryman, president and CEO of Democracy Forward who also the legal effort to make mifepristone available by mail during the COVID-19 pandemic as then-Chief Legal Officer and General Counsel of the American College of Obstetricians and Gynecologists, issued the following statement
“Women’s ability to access mifepristone through the mail or from their pharmacy has revolutionized access to care. Now, as anti-abortion extremists seek to employ their anti-abortion playbook and reverse this hard-fought victory for patients, this decision needlessly blocks people around the country from critical healthcare, discriminating in particular against those who live in rural and other areas where healthcare is inaccessible.
"Here's what is very clear: mifepristone has an OUTSTANDING safety record," said the Center for Reproductive Rights on Saturday. "It has been FDA-approved for 25 years and used by more than 7 million people."
Following Friday night's ruling by the 5th Circuit, Mini Timmaraju, president and CEO of the advocacy group Reproductive Freedom for All, said the stakes could night be higher for the right to choose in the United States.
"The court’s decision moves us one step closer to a national abortion ban," Timmaraju warned.
"It is now much more difficult for people to access abortion care," she said. "Anti-abortion politicians know their policies are unpopular, so they are using every lever of government they can. Louisiana built this case on debunked, junk science. The safety of mifepristone has never actually been in question. As this case moves towards the US Supreme Court, we will fight until every person has access to the care they need."
"Not a single combatant among them," said one human rights activist. "Further confirmation that over 90% of the victims are innocent civilians."
Israel's yearslong assault on Gaza has killed more than 38,000 women and girls, according to a report released Friday by the United Nations.
In total, the UN found that at least 22,000 women and 16,000 girls have been killed in the conflict, an average of nearly 50 women and girls per day.
Sofia Calltorp, chief of humanitarian action at UN Women, said the report shows how Israel's war on Gaza "has affected every aspect of life, with its most horrific toll seen in the scale of death."
"Women and girls accounted for a proportion of deaths far higher than those observed in previous conflicts in Gaza," Calltorp emphasized. "Those killed were mothers, they were daughters, sisters, and friends—deeply loved by those around them. They were individuals with lives and with dreams."
More than 72,000 people in total have been killed since Israel launched its attack on Gaza in October 2023, after Hamas invaded Israeli territory and killed approximately 1,200 Israelis. Experts warn that the current known death toll is likely an undercount.
While Palestinian women and girls represent more than half of those who have been killed, according to the report, Israeli and US officials have persisted in claiming the US-backed assault has targeted Hamas fighters.
"Not a single combatant among them," said Ramy Abdul, chairman of the Euro-Mediterranean Human Rights Monitor. "Further confirmation that over 90% of the victims are innocent civilians."
Although a ceasefire has been in place since October 2025, the report notes that an estimated 730 Gaza residents have been killed over the last six months. Additionally, the report says the humanitarian situation in Gaza remains dire.
“Nearly one million women and girls have been displaced, repeatedly," said Calltorp. “Access to water and food have been severely limited, with nearly 790,000 women and girls experiencing crisis-level or catastrophic levels of food insecurity. Extensive damage to infrastructure has made it almost impossible for women and girls in Gaza to access their basic needs, like healthcare."
Calltorp demanded that the ceasefire deal "be fully implemented," and that "respect for international law must be upheld" to ease the suffering in Gaza.
“Humanitarian assistance must reach those in need—at scale and without obstruction," Calltorp said. "And women and girls must be placed at the center of response and recovery efforts."
In addition to causing a humanitarian disaster in Gaza, Israel in recent weeks has also been waging an aerial bombing and ground invasion in Lebanon that has killed thousands of people and displaced more than 1 million. US President Donald Trump announced on Thursday that Israel and Lebanon came to a ceasefire agreement that is set to last for 10 days.
At the same time, Israeli settlers have been waging a campaign of increased violence against Palestinians living in the West Bank, and veteran Israeli war correspondent Ron Ben-Yishai on Thursday declared that the actions of the settlers look like "ethnic cleansing."
The genetic testing put forward by the committee "fuels suspicion, invites public scrutiny, and puts already vulnerable athletes at risk," said one advocate.
A new policy unveiled Thursday by the International Olympic Committee was presented as a ban on transgender athletes from participating in women's sports—but considering just one transgender woman has participated in the international games since they have been eligible to, critics said the new rules would likely have a greater impact on cisgender women with natural variations in hormones, who have already faced degrading treatment and exclusion in the sports community for years.
IOC president Kirsty Coventry, who campaigned to lead the organization with calls to "protect" women's sports in the Olympics, said that starting with the 2028 Summer Games in Los Angeles, athletes will be required to take a one-time genetics test with the screening using a cheek swab, blood test, or saliva sample.
"Eligibility for any female category event at the Olympic Games or any other IOC event, including individual and team sports, is now limited to biological females," said Coventry, adding that the new policy “is based on science and has been led by medical experts."
The IOC worked with experts to determine how to approach the issue of transgender women in sports, which in recent years has become the subject of talking points for the Republican Party in the US and other right-wing leaders. President Donald Trump signed an executive order last year barring transgender women from competing on women's college sports teams.
The committee conducted a review not just of transgender athletes but of those who have differences in sexual development (DSD), such as being intersex, and compete in women's sports. The review has not been publicly released, but the IOC said it found athletes born with male sexual markers had physical advantages even if they were receiving treatment to reduce testosterone.
The IOC had previously allowed transgender athletes to participate in the Olympic Games if they were reducing their testosterone levels. In 2021, a weight lifter from New Zealand, Laurel Hubbard, became the first transgender women to compete at the Olympics after transitioning.
Boxers including Lin Yu-Ting of Taiwan and Imane Khelif of Algeria have been subject to scrutiny and genetic testing regarding their sex; Lin was recently cleared to participate in World Boxing events in the female category. Both competed in the 2024 Olympics in Paris and won gold medals.
Khelif has said she naturally has the SRY gene that the IOC's screening would test for, and that she has naturally high levels of testosterone.
Under the IOC ruling, athletes who do not have the typical female XX sex chromosomes and have DSD will also be banned from competing. People with DSD are not always aware of their status.
South African runner Caster Semenya, who has a rare genetic trait giving her elevated levels of testosterone, was subjected to genetic testing after her fellow competitors complained about her appearance when she won a gold medal in a world championship in 2009.
Genetic screening for Olympic athletes "is not progress—it is walking backward," she told The New York Times. "This is just exclusion with a new name.”
Payoshni Mitra, executive director of the advocacy group Humans of Sport, told the Times that the new policy simply "polices women’s bodies."
“It fuels suspicion, invites public scrutiny, and puts already vulnerable athletes at risk," she said.